Review Article| Volume 30, ISSUE 3, P655-665, September 2010

Noninvasive Prenatal Diagnosis: 2010


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Evans M.I. Johnson M.P. Yaron Y. Prenatal diagnosis: genetics, reproductive risks, testing, and management. McGraw Hill Publishing Co, New York2006
        • Evans M.I.
        • Wapner R.J.
        Invasive prenatal diagnostic procedures 2005.
        Semin Perinatol. 2005; 29: 215-218
        • Evans M.I.
        • Krivchenia E.L.
        • Wapner R.J.
        • et al.
        Principles of screening.
        in: Evans M.I. Clinical obstetrics and gynecology – new genetics for the clinician. Lippincott, Williams & Wilkins, Philadelphia2002: 657-660
      2. Evans MI, Andriole S. Screening and testing in multiples. In: Odibo A, Krantz DA, editors. Prenatal screening and diagnosis clinics in laboratory medicine. Philadelphia: Elsevier Saunders Publishing C, in press.

        • Bianchi D.W.
        • Simpson J.L.
        • Jackson L.G.
        • et al.
        Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I Data.
        Prenat Diagn. 2002; 22: 609-615
        • Herzenberg L.A.
        • Bianchi D.W.
        • Schroeder J.
        • et al.
        Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting.
        Proc Natl Acad Sci U S A. 1979; 76: 1453-1455
      3. Hahn S. Holzgreve W. Fetal cells and fetal DNA in maternal blood: new developments for a new millennium. Karger Publishing Co, Basel (Switzerland)2001
        • Holzgreve W.
        • Zhong X.Y.
        • Troeger C.
        • et al.
        Fetal cells in maternal blood: an overview of the basel experience.
        in: Hahn S. Holzgreve W. Fetal cells and fetal DNA in maternal blood: new developments for a new millennium. Karger Publishing Co, Basel (Switzerland)2001: 28-36
        • Lo Y.M.D.
        • Tein M.S.
        • Lau T.K.
        • et al.
        Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.
        Am J Hum Genet. 1999; 64: 218-224
        • Lo Y.M.D.
        • Tsui N.B.Y.
        • Leung T.Y.
        • et al.
        Development of extraction protocols to improve the yield for fetal RNA in maternal plasma.
        Nat Med. 2007; 13: 218-223
        • Moise K.J.
        Management of Rhesus alloimmunization in pregnancy.
        Obstet Gynecol. 2008; 112: 164-176
        • Evans M.I.
        • Hyett J.
        • Nicolaides K.H.
        Genetic screening and clinical testing.
        in: Funai E. Evans M.I. Lockwood J. High risk obstetrics in the requisites in obstetrics and gynecology. Elsevier Science, Philadelphia2008: 33-60
        • Bischoff F.
        • Hahn S.
        • Johnson K.
        • et al.
        Intact fetal cells in maternal plasma: are they really there?.
        Lancet. 2003; 361: 139-140
        • Kilpatrick M.W.
        • Tafas T.
        • Evans M.I.
        • et al.
        Getting fetal cells in maternal blood to work: eliminating the false positive XY signals in XX pregnancies.
        Am J Obstet Gynecol. 2004; 190: 1571-1581
        • Seppo A.
        • Frisova V.
        • Ichetovkin I.
        • et al.
        Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies.
        Prenat Diagn. 2008; 28: 815-821
        • Huang R.
        • Barber T.A.
        • Schmidt M.A.
        • et al.
        A microfluidics approach for the solation of nucleated red blood cells (NRBCs) from peripheral blood of pregnant women.
        Prenat Diagn. 2008; 28: 892-899
        • Burgemeister R.
        New aspects of laser microdissection in research and routine.
        J Histochem Cytochem. 2005; 53: 409-412
        • Adinolfi M.
        • Sherlock J.
        First trimester prenatal diagnosis using transcervical cells: an evaluation.
        Hum Reprod Update. 1997; 3: 383-392
        • Fejgin M.D.
        • Diukman R.
        • Cotton Y.
        • et al.
        Fetal cells in the uterine cervix: a source for early non-invasive prenatal diagnosis.
        Prenat Diagn. 2001; 21: 619-621
        • Bussani C.
        • Cioni R.
        • Scarselli B.
        • et al.
        Strategies for the isolation and detection of fetal cells in transcervical samples.
        Prenat Diagn. 2002; 22: 1098-1101
        • Cioni R.
        • Bussani C.
        • Scarselli B.
        • et al.
        Comparison of two techniques for transcervical cell sampling performed in the same study population.
        Prenat Diagn. 2005; 25: 198-202
        • Rodeck C.
        • Tutschek B.
        • Sherlock J.
        • et al.
        Methods for the transcervical collection of fetal cells during the first trimester of pregnancy.
        Prenat Diagn. 1995; 15: 933-942
        • Massari A.
        • Novelli G.
        • Colosimo A.
        • et al.
        Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells.
        Hum Genet. 1996; 97: 150-155
        • Katz-Jaffe M.G.
        • Mantzaris D.
        • Cram D.S.
        DNA identification of fetal cells isolated from cervical mucus: potential for early non-invasive prenatal diagnosis.
        BJOG. 2005; 112: 595-600
        • Lo Y.M.D.
        • Corbetta N.
        • Chamberlain P.F.
        • et al.
        Presence of fetal DNA in maternal plasma and serum.
        Lancet. 1997; 350: 485-487
        • Chan K.C.A.
        • Zhang J.
        • Jui A.B.
        • et al.
        Size distributions of maternal and fetal DNA in maternal plasma.
        Clin Chem. 2004; 50: 88-92
        • Li Y.
        • DiNaro E.
        • Vitucci A.
        • et al.
        Detection of paternally inherited fetal point mutations for beta-thalassemia using size fractionated cell free DNA in maternal plasma.
        JAMA. 2005; 293: 843-849
        • Poon L.L.M.
        • Leung T.N.
        • Lau T.K.
        • et al.
        Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma.
        Clin Chem. 2002; 48: 35-41
        • Chim S.S.C.
        • Tong Y.K.
        • Chiu R.W.K.
        • et al.
        Detection of the placental epigenetic signature of the maspin gene in maternal plasma.
        Clin Chem. 2002; 48: 35-41
        • Lo Y.M.D.
        Non invasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
        Br J Obstet Gynaecol. 2009; 116: 152-157
      4. (Available at:) (Accessed June 1, 2010)
        • Lo Y.M.D.
        • Lun F.M.F.
        • Chan K.C.A.
        • et al.
        Digital PCR for the molecular detection of fetal chromosomal aneuploidy.
        Proc Natl Acad Sci U S A. 2007; 104: 13116-13121
        • Fan H.C.
        • Blumenfeld Y.J.
        • El-Sayed Y.Y.
        • et al.
        Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy.
        Am J Obstet Gynecol. 2009; 200 (e1–543.e7): 543
        • Vogelstein B.
        • Kintzler K.W.
        Digital PCR.
        Proc Natl Acad Sci U S A. 1999; 96: 9236-9241
        • Hahn S.
        • Jackson L.G.
        • Kolla V.
        • et al.
        Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies.
        Expert Rev Mol Diagn. 2009; 9: 613-621
        • Fan H.C.
        • Blumenfeld Y.J.
        • Chirkara U.
        • et al.
        Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.
        Proc Natl Acad Sci U S A. 2008; 105: 16266-16271
        • Chiu R.W.
        • Chan K.C.
        • Gao Y.
        • et al.
        Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.
        Proc Natl Acad Sci U S A. 2008; 105: 20458-20463
        • Geifman-Holtzman O.
        • Grotegut C.A.
        • Gaughan J.P.
        Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood – a meta analysis.
        Am J Obstet Gynecol. 2006; 195: 1163-1173
        • Brown S.
        • Kellner L.H.
        • Munson M.
        • et al.
        Non-invasive prenatal testing: technical strategies to achieve testing of cell free fetal DNA RhD genotype in a clinical lab.
        Am J Obstet Gynecol. 2007; 197: S173
        • Chiu R.W.K.
        • Lau T.K.
        • Leung T.N.
        • et al.
        Prenatal exclusion of beta thalassaemia major by examination of maternal plasma.
        Lancet. 2002; 360: 998-1000
        • Li Y.
        • Page-Christiaens G.C.
        • Gille J.J.
        • et al.
        Non-invasive prenatal detection of achondroplasia in size fractionated cell-free DNA by MALDI-TOF MS assay.
        Prenat Diagn. 2007; 27: 11-17
        • Scheffer P.G.
        • van der Schoot C.E.
        • Godelieve C.M.L.
        • et al.
        Reliability of fetal sex determination using maternal plasma.
        Obstet Gynecol. 2010; 115: 117-126
        • Baker C.
        • Feldman B.
        • Shalhoub A.G.
        • et al.
        Demographic factors for utilization of invasive genetic testing after multifetal pregnancy reduction (MFPR).
        Fetal Diagn Ther. 2003; 18: 140-143
        • Abuhamad A.
        • Chaoui R.
        A practical guide to fetal echocardiography.
        2nd edition. Wolters Kluwer/Lippincott, Philadelphia2010
        • Malone F.D.
        • Canick J.A.
        • Ball R.H.
        • et al.
        First trimester or second trimester screening or both for Down's Syndrome.
        N Engl J Med. 2005; 353: 2001-2011
        • Henry G.P.
        • Britt D.W.
        • Evans M.I.
        Screening advances and diagnostic choice: the problem of residual risk.
        Fetal Diagn Ther. 2008; 23: 308-315
        • Evans M.I.
        • Pergament E.
        Impact of quality of nuchal translucency measurements on detection rates of Trisomies 13 and 18.
        Fetal Diagn Ther. 2010; 27: 68-71
        • Zamerowski S.T.
        • Lumley M.A.
        • Arreola R.A.
        • et al.
        Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood.
        Genet Med. 2001; 4: 301-309